161 related articles for article (PubMed ID: 25405889)
21. [Development status of new antibacterials].
Yamano Y
Nihon Rinsho; 2012 Feb; 70(2):315-9. PubMed ID: 22413538
[TBL] [Abstract][Full Text] [Related]
22. Pili with strong attachments: Gram-positive bacteria do it differently.
Scott JR; Zähner D
Mol Microbiol; 2006 Oct; 62(2):320-30. PubMed ID: 16978260
[TBL] [Abstract][Full Text] [Related]
23. [Bacteria: able to learn and adapt. Disease pathogens protect themselves through various resistance mechanisms].
Heinzl S
Med Monatsschr Pharm; 2006 Dec; 29(12):430-2. PubMed ID: 17220036
[No Abstract] [Full Text] [Related]
24. DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 1: Internal benzimidazole derivatives.
Bürli RW; McMinn D; Kaizerman JA; Hu W; Ge Y; Pack Q; Jiang V; Gross M; Garcia M; Tanaka R; Moser HE
Bioorg Med Chem Lett; 2004 Mar; 14(5):1253-7. PubMed ID: 14980676
[TBL] [Abstract][Full Text] [Related]
25. Development of antivirulence compounds: a biochemical review.
Zambelloni R; Marquez R; Roe AJ
Chem Biol Drug Des; 2015 Jan; 85(1):43-55. PubMed ID: 25521644
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of sortase-mediated Staphylococcus aureus adhesion to fibronectin via fibronectin-binding protein by sortase inhibitors.
Oh KB; Oh MN; Kim JG; Shin DS; Shin J
Appl Microbiol Biotechnol; 2006 Mar; 70(1):102-6. PubMed ID: 16010573
[TBL] [Abstract][Full Text] [Related]
27. Crystallography of gram-positive bacterial adhesins.
Krishnan V; Narayana SV
Adv Exp Med Biol; 2011; 715():175-95. PubMed ID: 21557064
[TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
Rybak MJ
Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
[TBL] [Abstract][Full Text] [Related]
30. Anti-adhesion methods as novel therapeutics for bacterial infections.
Cozens D; Read RC
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1457-68. PubMed ID: 23253323
[TBL] [Abstract][Full Text] [Related]
31. Thrombospondin-1 promotes cellular adherence of gram-positive pathogens via recognition of peptidoglycan.
Rennemeier C; Hammerschmidt S; Niemann S; Inamura S; Zähringer U; Kehrel BE
FASEB J; 2007 Oct; 21(12):3118-32. PubMed ID: 17507668
[TBL] [Abstract][Full Text] [Related]
32. Natural Green coating inhibits adhesion of clinically important bacteria.
Trentin DS; Silva DB; Frasson AP; Rzhepishevska O; da Silva MV; Pulcini Ede L; James G; Soares GV; Tasca T; Ramstedt M; Giordani RB; Lopes NP; Macedo AJ
Sci Rep; 2015 Feb; 5():8287. PubMed ID: 25655943
[TBL] [Abstract][Full Text] [Related]
33. Pleuromutilin derivatives having a purine ring. Part 1: new compounds with promising antibacterial activity against resistant Gram-positive pathogens.
Hirokawa Y; Kinoshita H; Tanaka T; Nakamura T; Fujimoto K; Kashimoto S; Kojima T; Kato S
Bioorg Med Chem Lett; 2008 Jun; 18(12):3556-61. PubMed ID: 18511280
[TBL] [Abstract][Full Text] [Related]
34. Modulation of antibiotic resistance in bacterial pathogens by oleanolic acid and ursolic acid.
Kurek A; Nadkowska P; Pliszka S; Wolska KI
Phytomedicine; 2012 Apr; 19(6):515-9. PubMed ID: 22341643
[TBL] [Abstract][Full Text] [Related]
35. Comparative in vitro activity of imipenem and nine other antimicrobials against recently isolated pathogens.
Bonadio M; Maccanti O; Cosci S; Giordani R
J Chemother; 1989 Jul; 1(4 Suppl):58-60. PubMed ID: 16312303
[No Abstract] [Full Text] [Related]
36. Future antibiotics scenarios: is the tide starting to turn?
Theuretzbacher U
Int J Antimicrob Agents; 2009 Jul; 34(1):15-20. PubMed ID: 19342202
[TBL] [Abstract][Full Text] [Related]
37. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
Roveta S; Marchese A; Debbia EA
Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
[TBL] [Abstract][Full Text] [Related]
38. Structure-guided discovery of 1,3,5-triazine-pyrazole conjugates as antibacterial and antibiofilm agent against pathogens causing human diseases with favorable metabolic fate.
Singh B; Bhat HR; Kumawat MK; Singh UP
Bioorg Med Chem Lett; 2014 Aug; 24(15):3321-5. PubMed ID: 24961639
[TBL] [Abstract][Full Text] [Related]
39. Pili of gram-positive bacteria: roles in host colonization.
Danne C; Dramsi S
Res Microbiol; 2012; 163(9-10):645-58. PubMed ID: 23116627
[TBL] [Abstract][Full Text] [Related]
40. Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.
Freire-Moran L; Aronsson B; Manz C; Gyssens IC; So AD; Monnet DL; Cars O;
Drug Resist Updat; 2011 Apr; 14(2):118-24. PubMed ID: 21435939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
